CDCB Welcomes

Sophia Bornstein, MD, PhDCDCB is pleased to welcome Sophia Bornstein, M.D., Ph.D., now as an Assistant Professor and Attending Physician with a primary appointment in Radiation Medicine, and a secondary appointment in CDCB. Dr. Bornstein officially started as an Assistant Professor and a director of the program in translational research in the Department of Radiation Medicine on October 1st. Her appointment is part of the wider Knight Cancer Institute initiative to create an environment of bedside to bench and back to bedside approach that combines patient care with research. This recruitment is transformational and represents an inflection point in the trajectory of our department as we build bridges with our clinical colleagues and departments. Welcome, Sophia!

CDCB Recognitions

Congratulations to the following recipients of awards and recognitions!

Amanda Lund, Ph.D., awarded the V Foundation for Cancer Research Award for her project, "Lymphatic Vessel, PD-Land Anti-Tumor Immunity."

Nick Smith, Ph.D., Wong Lab, awarded the Nicholas L. Tartar Research Fellowship for his proposal, “Activation of Tumor Immune Cells by CD166 over-expressing Cancer Cells."

Amanda Lund, Ph.D., awarded the Cancer Research Institute's Clinic and Laboratory Integration Program (CLIP) Grant for her project "FasL Expressing Lymphatic Vessels in Melanoma.”

Ningning Zhao, Ph.D., Enns Lab, accepted to the Visiting Scientist Program at the Center for Cell Circuits for a summer internship at the Broad Institute of MIT and Harvard.

Pepper Schedin, Ph.D., awarded the Circle of Giving Grant from the OHSU Center for Women’s Health, for “A Liver Imaging Study in Pregnant Women.”

Takahiro Tsujikawa, Coussens Lab, won the OCTRI Catalyst Award, for “Practical and cost-effective multiplexed immunohistochemistry for comprehensive immune complexity analysis of solid tumors.”

Research week winners Ryan Lane, Lund Lab, #1 Poster Presentation; Erica Goddard, Schedin Lab, #2 Oral Presentation; Marilynn Chow, Tyner Lab, #9 Oral Presentation.

Chelsea Jenkins, Tyner Lab, won the Oregon Students Learn and Experience Research (OSLER) TL 1 year-long training award from the Oregon Clinical and Translational Research Institute (OCTRI). 

Chelsea was also awarded the 2015 Friends of Doernbecher grant, for “Developing Novel Treatments for Childhood Leukemia Patients with JMML.”

Branden Tarlow, Grompe Lab, won the 2015 Resko Outstanding Doctoral Disseration Award, for “Cellular Plasticity in Liver Injury: Origin of Progenitors and Mechanisms of Regeneration.”

Sara Courtneidge, Ph.D., awarded the AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship. She delivered her lecture “Cancer Cell Invasion and Metastasis" at the 2015 AACR Annual Meeting.

 CDCB in the news

Jeffrey Tyner, Ph.D., earned the Martin and Rose Wachtel Cancer Research Award from the American Association for the Advancement of Science (AAAS). Read more
Dr. Tyner's accomplishment was recognized in the July 4, 2014 issue of The Cancer LetterRead Dr. Tyner's prize essay in Science Translational Medicine.

Dr. Caroline Enns was elected to the American Association for the Advancement of Science (AAAS) this year for outstanding fundamental research discoveries on the biochemical, cell biological, and physiological mechanisms underlying iron homeostasis and its regulation. Read more.

CDCB postdoctoral fellow Alain Silk of the Wong lab presented a poster at the American Society for Cell Biology Annual Meeting in New Orleans and had an article written about the lab's work in The Scientist. Read more.


OHSU cancer researcher aims to make cancer a manageable disease

About one in three Americans will be diagnosed with cancer in their lifetimes, and close to 600,000 will die as a result this year. Lisa Coussens hopes to dramatically reduce that number, making cancer a manageable disease instead of a deadly one. While traditional cancer research focuses on the malignant cells themselves, Coussens, a professor at the Knight Cancer Institute at the Oregon Health and Science University, is part of a new wave of biologists investigating the surrounding microenvironment. Read more.

OHSU researching new breast cancer drug

Women with the most aggressive form of breast cancer are getting some new hope from research done right here in Portland. Women with triple negative breast cancer don't usually respond to the most traditional therapies. The prognosis is also another five to eight years to live, but this new research is aiming at extending that. Read more.